A new, Yale-led study suggests that a range of respiratory viral infections — including COVID-19 and influenza — may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
A team led by Yale’s Akiko Iwasaki and...
Proposed changes to the United States’ Medicare and Medicaid programs could lead to thousands of additional deaths each year, a new Yale study reveals.
Recent proposals to reduce program costs include a recommendation to raise the eligibility age for...
Mental illness costs the U.S. economy $282 billion annually, which is equivalent to the average economic recession, according to a new study co-authored by Yale economist Aleh Tsyvinski.
The first-of-its-kind study integrates psychiatric scholarship with...
Antibiotic-resistant bacteria are a growing problem when it comes to combatting infections. Bacteria that have an additional protective layer to their cell walls — a type known as “Gram-negative” in reference to the staining method used to identify it —...
Since Yale researchers first observed the ability of the anesthetic ketamine to dramatically improve symptoms in many patients with treatment-resistant depression more than two decades ago, the drug has provided a powerful new therapeutic option for...